Treatment of buccal mucosal carcinomas: A survey amongst head and neck surgeons in the Netherlands
Abstract Objective Currently, there is no up‐to‐date guideline for the treatment of buccal mucosal squamous cell carcinoma (BMSCC) in the Netherlands. A questionnaire was used to investigate the opinions of Dutch head and neck surgeons on BMSCC of the cheek treatment. Methods A questionnaire was sen...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-08-01
|
| Series: | Laryngoscope Investigative Otolaryngology |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/lio2.1081 |
| _version_ | 1797738288891559936 |
|---|---|
| author | Carleen M. E. M. Adriaansens Rob Noorlag Remco deBree Robert J. J. vanEs |
| author_facet | Carleen M. E. M. Adriaansens Rob Noorlag Remco deBree Robert J. J. vanEs |
| author_sort | Carleen M. E. M. Adriaansens |
| collection | DOAJ |
| description | Abstract Objective Currently, there is no up‐to‐date guideline for the treatment of buccal mucosal squamous cell carcinoma (BMSCC) in the Netherlands. A questionnaire was used to investigate the opinions of Dutch head and neck surgeons on BMSCC of the cheek treatment. Methods A questionnaire was sent to all 91 head and neck surgeons in the Netherlands. Their opinions on surgical tumor‐free margins, through‐and‐through defects, and indications for local adjuvant therapy were questioned. Results The response rate was 51%. To prevent a through‐and‐through defect, 67% of the surgeons would accept a deep clinical (macroscopic) margin of ≤5 mm. The less adverse histological characteristics a tumor has, the less consensus there is amongst the surgeons for local adjuvant treatment in case of close margins. Conclusion There is no consensus amongst Dutch head and neck surgeons about the optimal treatment for BMSCC of the cheek. There are different opinions on acceptable resection margins, indications for a through‐and‐through defect, and indications for adjuvant treatment. BMSCC of the cheek treatment should be more uniform and less surgeon dependent. Level of evidence N/A |
| first_indexed | 2024-03-12T13:41:41Z |
| format | Article |
| id | doaj.art-ea7ad2895dd64c618e5260cebe3e8b75 |
| institution | Directory Open Access Journal |
| issn | 2378-8038 |
| language | English |
| last_indexed | 2024-03-12T13:41:41Z |
| publishDate | 2023-08-01 |
| publisher | Wiley |
| record_format | Article |
| series | Laryngoscope Investigative Otolaryngology |
| spelling | doaj.art-ea7ad2895dd64c618e5260cebe3e8b752023-08-23T18:20:17ZengWileyLaryngoscope Investigative Otolaryngology2378-80382023-08-018485786410.1002/lio2.1081Treatment of buccal mucosal carcinomas: A survey amongst head and neck surgeons in the NetherlandsCarleen M. E. M. Adriaansens0Rob Noorlag1Remco deBree2Robert J. J. vanEs3Department of Head and Neck Surgical Oncology University Medical Center Utrecht Utrecht the NetherlandsDepartment of Head and Neck Surgical Oncology University Medical Center Utrecht Utrecht the NetherlandsDepartment of Head and Neck Surgical Oncology University Medical Center Utrecht Utrecht the NetherlandsDepartment of Head and Neck Surgical Oncology University Medical Center Utrecht Utrecht the NetherlandsAbstract Objective Currently, there is no up‐to‐date guideline for the treatment of buccal mucosal squamous cell carcinoma (BMSCC) in the Netherlands. A questionnaire was used to investigate the opinions of Dutch head and neck surgeons on BMSCC of the cheek treatment. Methods A questionnaire was sent to all 91 head and neck surgeons in the Netherlands. Their opinions on surgical tumor‐free margins, through‐and‐through defects, and indications for local adjuvant therapy were questioned. Results The response rate was 51%. To prevent a through‐and‐through defect, 67% of the surgeons would accept a deep clinical (macroscopic) margin of ≤5 mm. The less adverse histological characteristics a tumor has, the less consensus there is amongst the surgeons for local adjuvant treatment in case of close margins. Conclusion There is no consensus amongst Dutch head and neck surgeons about the optimal treatment for BMSCC of the cheek. There are different opinions on acceptable resection margins, indications for a through‐and‐through defect, and indications for adjuvant treatment. BMSCC of the cheek treatment should be more uniform and less surgeon dependent. Level of evidence N/Ahttps://doi.org/10.1002/lio2.1081buccal mucosal squamous cell carcinomahead and neck surgeonquestionnairethrough‐and‐through defectultrasound |
| spellingShingle | Carleen M. E. M. Adriaansens Rob Noorlag Remco deBree Robert J. J. vanEs Treatment of buccal mucosal carcinomas: A survey amongst head and neck surgeons in the Netherlands Laryngoscope Investigative Otolaryngology buccal mucosal squamous cell carcinoma head and neck surgeon questionnaire through‐and‐through defect ultrasound |
| title | Treatment of buccal mucosal carcinomas: A survey amongst head and neck surgeons in the Netherlands |
| title_full | Treatment of buccal mucosal carcinomas: A survey amongst head and neck surgeons in the Netherlands |
| title_fullStr | Treatment of buccal mucosal carcinomas: A survey amongst head and neck surgeons in the Netherlands |
| title_full_unstemmed | Treatment of buccal mucosal carcinomas: A survey amongst head and neck surgeons in the Netherlands |
| title_short | Treatment of buccal mucosal carcinomas: A survey amongst head and neck surgeons in the Netherlands |
| title_sort | treatment of buccal mucosal carcinomas a survey amongst head and neck surgeons in the netherlands |
| topic | buccal mucosal squamous cell carcinoma head and neck surgeon questionnaire through‐and‐through defect ultrasound |
| url | https://doi.org/10.1002/lio2.1081 |
| work_keys_str_mv | AT carleenmemadriaansens treatmentofbuccalmucosalcarcinomasasurveyamongstheadandnecksurgeonsinthenetherlands AT robnoorlag treatmentofbuccalmucosalcarcinomasasurveyamongstheadandnecksurgeonsinthenetherlands AT remcodebree treatmentofbuccalmucosalcarcinomasasurveyamongstheadandnecksurgeonsinthenetherlands AT robertjjvanes treatmentofbuccalmucosalcarcinomasasurveyamongstheadandnecksurgeonsinthenetherlands |